Wang Y, Luo W, Han J et al (2020) MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy
In the landmark SURMOUNT-1 trial, participants on the 15 mg dose achieved average weight loss of 22.5% of body weight over 72 weeks
In chronic metabolic states like obesity and T2DM, the GLP-1R signaling axis undergoes significant alterations that drive incretin resistance and impaired glucose control (Tzeravini et al., 2026)
thus, most current treatments are prescribed for alleviating symptoms only
Mitochondrial dysfunction model: The role of cellular metabolism in differentiation was studied using a mouse model with mitochondrial dysfunction ( mice), where ClpP, a mitochondrial matrix peptidase, is knocked out in intestinal epithelial cells
(2014) Cell 156, 317-331